Biosimilars can cost $600 a month versus $6,000 for branded rivals, but PBM rebate incentives push formularies toward pricier ...

CMS’ mandatory GLOBE drug model ties some Medicare Part B rebates to global prices, but cuts projected savings sharply amid ...

Some predicted that drugmakers might boost launch prices to make up for Medicare drug negotiations shrinking profits. Harvard ...

Tariffs on patented drugs broaden beyond Big Pharma, and exemptions, MFN deals and origin caps determine rates and potential ...

State PBM reform accelerates through 2026, with Theresa Carnegie of Mintz unpacking new laws, rebate pass-through, spread ...

The newest wave of cancer therapies, including CAR-T cell therapy, bispecific antibodies and antibody-drug conjugates, is ...

In this discussion, Ohio State economist Eric Seiber, Ph.D., explains how inconsistent claims-data definitions can skew ...

Teledentistry has become an important tool for helping patients access dental expertise when and where they need it. It can ...

Meta-analysis of 13 RCTs (2002–2024; eight countries) found VR reduced pain (SMD −0.76) and anxiety (SMD −1.53), largely ...

Poh says treatment of follicular lymphoma is entering an exciting era in follicular lymphoma with multiple treatment options ...

Employers that decide to stop covering GLP-1s for weight loss are increasingly pairing that decision with support for the ...

Fewer than one in five young people with first episode psychosis filled enough antipsychotic prescriptions to be considered ...